Loading clinical trials...
Loading clinical trials...
A Clinical Trial to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of an Engineered Mitochondrial Vaccine in Treatment of Advanced Solid Tumors
Conditions
Interventions
Engineered mitochondrial vaccine
Locations
1
China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Start Date
May 9, 2025
Primary Completion Date
December 31, 2026
Completion Date
April 30, 2028
Last Updated
March 17, 2026
NCT07299747
NCT06760481
NCT04521413
NCT03363893
NCT05573724
NCT02347228
Lead Sponsor
West China Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions